BioHarvest Sciences (TSE:BHSC) has released an update.
BioHarvest Sciences has announced a significant year-over-year revenue jump of 119% in Q2 2024, crossing the $6 million mark for the first time and projecting at least $6.5 million for Q3 with a strong gross profit margin of over 52%. The company has also seen a substantial increase in VINIA® subscribers and has bolstered its financial position with a recent private placement and plans for a Nasdaq listing.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
